Mapping Disease Transitions from Premalignant, Asymptomatic to Advanced Myeloma through Integrative Epigenomic and Transcriptional Analyses
Aleksandra K. Kurowska, Azari Bantan, Raghad Shuwaikan…·David Gómez-Cabrero
This study maps epigenetic and transcriptional changes in myeloma progression from precursor to advanced stages, identifying key transcription factors involved in disease development.